Annual Report 2021

  • Overview
    • Overview
    • Editorial
    • Key figures
    • Profile
    • Strategy
  • Business Review
    • Business Review
    • Growth driven by custom projects
    • Increase in profitability
    • Accelerated capital deployment
    • New capabilities in oligonucleotides
    • Integrated ESG management
    • Organizational progress
    • Risk management and internal audit
    • Employees and people development
    • Dividend
    • Outlook for 2022
  • Corporate Responsibility
    • Corporate Responsibility
    • ESG governance
    • ESG materiality assessment
    • Integrated ESG management
    • ESG agenda
  • Governance and Remuneration
    • Governance and Remuneration
    • Corporate Governance Report
      • Corporate Governance Report
      • Corporate Governance Report 2021
      • Group structure and shareholders
      • Capital structure
      • Board of Directors
      • Executive Committee
      • Compensation, shareholdings and loans
      • Shareholders’ participation rights
      • Change of control and defense measures
      • Auditors
      • Information policy
      • Quiet periods
    • Remuneration Report
      • Remuneration Report
      • Letter from the Chairman of the Remuneration and Nomination Committee
      • Remuneration Report 2021
      • Remuneration governance
      • Remuneration philosophy and principles
      • Agreements related to the compensation for Members of the Board of Directors and the Executive Committee
      • Compensation framework for the Board of Directors
      • Compensation framework for the Executive Committee
      • IPO Recognition Bonus
      • Ownership of shares and options
      • Other remuneration-related information under the OAEC
      • Report on the Audit of the Remuneration Report
  • Financial Report
    • Financial Report
    • Consolidated financial statements
      • Consolidated financial statements
      • Consolidated income statement
      • Consolidated statement of comprehensive income
      • Consolidated statement of financial position
      • Consolidated statement of changes in equity
      • Consolidated statement of cash flows
      • Notes to the consolidated financial statements
      • Report of the statutory auditor
      • Three-year Financial History
    • Financial statements of PolyPeptide Group AG
      • Financial statements of PolyPeptide Group AG
      • Income statement of PolyPeptide Group AG
      • Statement of financial position of PolyPeptide Group AG
      • Notes to the financial statements of PolyPeptide Group AG
      • Report on the Audit of the Financial Statements of PolyPeptide Group AG
  • Definitions and reconciliations
    • Definitions and reconciliations
    • Abbreviations
    • Operational indicators
    • Alternative Financial Measures (APM)
    • Reconciliations

Annual Report 2021

Download-Center

Annual Report 2021 PDF | 11 MB
Company overview 2021 PDF | 3 MB
Corporate Governance Report 2021 PDF | 4 MB
Remuneration Report 2021 PDF | 1 MB
Financial Report 2021 PDF | 3 MB

Archive

Half-year Report 2021 PDF | 1 MB
Downloads Annual ReportCompany overviewCorporate Governance ReportRemuneration ReportFinancial Report

PolyPeptide Group AG

Dammstrasse 19
6300 Zug
Switzerland

+41 (0) 41 723 20 34
info@polypeptide.com
www.polypeptide.com

  • © PolyPeptide 2022
  • Privacy Policy
  • Imprint
  • Legal Note